We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPR
1251
DELISTED
HighPoint Resources Corporation
HPR
$317K ﹤0.01%
2,869
+1,009
+54% +$134K
SREV
1252
DELISTED
ServiceSource International, Inc.
SREV
$315K ﹤0.01%
342,566
-122,476
-26% -$128K
VG
1253
DELISTED
Vonage Holdings Corporation
VG
$314K ﹤0.01%
31,258
-2,798,677
-99% -$26.9M
DISCK
1254
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$312K ﹤0.01%
12,276
-143,712
-92% -$3.76M
CASS icon
1255
Cass Information Systems
CASS
$710M
$309K ﹤0.01%
+6,532
New +$334K
ZEPP
1256
Zepp Health
ZEPP
$71.6M
$309K ﹤0.01%
5,894
+5,741
+3,752% +$310K
ERII icon
1257
Energy Recovery
ERII
$434M
$308K ﹤0.01%
+35,227
New +$280K
SCM icon
1258
Stellus Capital Investment Corp
SCM
$210M
$306K ﹤0.01%
21,637
-85,396
-80% -$1.21M
TYPE
1259
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$306K ﹤0.01%
15,392
-425,793
-97% -$7.67M
AKBA icon
1260
Akebia Therapeutics
AKBA
$341M
$305K ﹤0.01%
37,263
-496,678
-93% -$3.41M
GTT
1261
DELISTED
GTT Communications, Inc.
GTT
$304K ﹤0.01%
8,750
-12,113
-58% -$356K
QQQ icon
1262
PUT
Invesco QQQ Trust
QQQ
$446B
$302K ﹤0.01%
+1,700
New +$288K
YUMC icon
1263
Yum China
YUMC
$15.3B
$301K ﹤0.01%
6,695
-483,660
-99% -$19.1M
TLND
1264
DELISTED
Talend S.A. American Depositary Shares
TLND
$297K ﹤0.01%
5,877
-376,664
-98% -$16.1M
HIFR
1265
DELISTED
InfraREIT, Inc.
HIFR
$297K ﹤0.01%
+14,153
New +$300K
IYC icon
1266
iShares US Consumer Discretionary ETF
IYC
$1.14B
$295K ﹤0.01%
5,776
-4,460
-44% -$219K
CCBG icon
1267
Capital City Bank Group
CCBG
$892M
$293K ﹤0.01%
+13,436
New +$321K
ALDR
1268
DELISTED
Alder Biopharmaceuticals
ALDR
$289K ﹤0.01%
+21,180
New +$274K
VIA
1269
DELISTED
Viacom Inc. Class A
VIA
$287K ﹤0.01%
8,836
-19,902
-69% -$663K
ATRA icon
1270
Atara Biotherapeutics
ATRA
$71M
$284K ﹤0.01%
+286
New +$266K
SAIC icon
1271
Saic
SAIC
$5B
$284K ﹤0.01%
3,686
-1,603
-30% -$113K
TCRT icon
1272
Alaunos Therapeutics
TCRT
$4.71M
$283K ﹤0.01%
491
-2,069
-81% -$865K
QIWI
1273
DELISTED
QIWI PLC
QIWI
$283K ﹤0.01%
+19,692
New +$288K
GPRO icon
1274
GoPro
GPRO
$119M
$282K ﹤0.01%
+43,464
New +$243K
CYBE
1275
DELISTED
Cyberoptics Corp
CYBE
$282K ﹤0.01%
+16,501
New +$327K

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.